Sitagliptin / Metformin -- Benefit Assessment According to §35a Social Code Book V [Internet].

The benefit assessment of the fixed combination of sitagliptin and metformin (hereinafter referred to as "sitagliptin / metformin") was conducted in accordance with its approval status for the following therapeutic indication: treatment of adult patients with type 2 diabetes mellitus as an adjunct to diet and exercise.

http://ift.tt/2t26fqO